Facing Up to the Challenges of EU Joint Clinical Assessments
Joint Clinical Assessment is central to the success of the European Union Health Technology Assessment (EU HTA) Regulation but there are challenges ahead for the oncology, rare disease and advanced therapy medicinal product sectors.
Whitepaper Mar 31, 2023
Portfolio Co-positioning
Playing Nicely With Friends: Portfolio Co-positioning
Portfolio co-positioning refers to the commercialization of one or more assets by the same company in the same area. Determining which asset is targeted to which patient segment requires a robust and objective process. So, what is the best practice approach to portfolio co-positioning?
Whitepaper Sep 12, 2022